US Foot and Ankle Allograft Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2024


In this region, U.S. foot and ankle allograft market is projected to reach USD 138.04 million by 2024 from USD 95.05 million in 2016, at a CAGR of 4.8% in the forecast period 2017 to 2024
Integra LifeSciences Corporation is going to dominate the U.S. foot and ankle allograft market following with CONMED Corporation and Wright Medical Group N.V., along with others such as Stryker,
Zimmer Biomet,
Lattice Biologics Ltd.,
Bone Bank allografts,

RTI surgical, Inc.,
Arthrex Inc.,
JRF Ortho and AlloSource.
The U.S. foot and ankle allograft market is segmented on the basis of surgery type and end user. The U.S. foot and ankle allograft market is segmented into 6 types: allograft wedges, allograft tendons, allograft acellular dermal matrix, cartilage allograft matrix, skin allografts, and amniotic membranes.
On the basis of end users, the market is classified into orthopedic clinics, hospitals and ambulatory surgical centres.